Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Buferne

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Immunology|January 6, 2010
Cooperative action of CD8 T lymphocytes and natural killer cells controls tumour growth under conditions of restricted T-cell receptor diversityAnil Shanker, Michel Buferne, Anne-Marie Schmitt-Verhulst
Cancer Research|November 9, 2011
Activated STAT5 promotes long-lived cytotoxic CD8+ T cells that induce regression of autochthonous melanomaMagali Grange, Michel Buferne, Grégory Verdeil, et al.
International Immunology|December 3, 2003
Differential implication of protein kinase C isoforms in cytotoxic T lymphocyte degranulation and TCR-induced Fas ligand expressionJulián Pardo, Michel Buferne, María-José Martínez-Lorenzo, et al.
Pigment Cell & Melanoma Research|December 11, 2012
Immunosuppression in inflammatory melanoma: can it be resisted by adoptively transferred T cells?Nathalie Auphan-Anezin, Grégory Verdeil, Magali Grange, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2013
Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signalingMagali Grange, Grégory Verdeil, Fanny Arnoux, et al.
Oncoimmunology|May 8, 2015
IFNγ producing CD8<sup>+</sup> T cells modified to resist major immune checkpoints induce regression of MHC class I-deficient melanomasMichel Buferne, Lionel Chasson, Magali Grange, et al.
Immunology|October 8, 2016
Distinct patterns of cytolytic T-cell activation by different tumour cells revealed by Ca<sup>2+</sup> signalling and granule mobilizationMelissa Frick, Pierre Mouchacca, Grégory Verdeil, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2007
CD8 T cell help for innate antitumor immunityAnil Shanker, Grégory Verdeil, Michel Buferne, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2014
The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cellsMarilyn Giordano, Romain Roncagalli, Pierre Bourdely, et al.
The EMBO Journal|July 4, 2015
Molecular profiling of CD8 T cells in autochthonous melanoma identifies Maf as driver of exhaustionMarilyn Giordano, Coralie Henin, Julien Maurizio, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Immunology|January 6, 2010
Cooperative action of CD8 T lymphocytes and natural killer cells controls tumour growth under conditions of restricted T-cell receptor diversityAnil Shanker, Michel Buferne, Anne-Marie Schmitt-Verhulst
Cancer Research|November 9, 2011
Activated STAT5 promotes long-lived cytotoxic CD8+ T cells that induce regression of autochthonous melanomaMagali Grange, Michel Buferne, Grégory Verdeil, et al.
International Immunology|December 3, 2003
Differential implication of protein kinase C isoforms in cytotoxic T lymphocyte degranulation and TCR-induced Fas ligand expressionJulián Pardo, Michel Buferne, María-José Martínez-Lorenzo, et al.
Pigment Cell & Melanoma Research|December 11, 2012
Immunosuppression in inflammatory melanoma: can it be resisted by adoptively transferred T cells?Nathalie Auphan-Anezin, Grégory Verdeil, Magali Grange, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2013
Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signalingMagali Grange, Grégory Verdeil, Fanny Arnoux, et al.
Oncoimmunology|May 8, 2015
IFNγ producing CD8<sup>+</sup> T cells modified to resist major immune checkpoints induce regression of MHC class I-deficient melanomasMichel Buferne, Lionel Chasson, Magali Grange, et al.
Immunology|October 8, 2016
Distinct patterns of cytolytic T-cell activation by different tumour cells revealed by Ca<sup>2+</sup> signalling and granule mobilizationMelissa Frick, Pierre Mouchacca, Grégory Verdeil, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2007
CD8 T cell help for innate antitumor immunityAnil Shanker, Grégory Verdeil, Michel Buferne, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2014
The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cellsMarilyn Giordano, Romain Roncagalli, Pierre Bourdely, et al.
The EMBO Journal|July 4, 2015
Molecular profiling of CD8 T cells in autochthonous melanoma identifies Maf as driver of exhaustionMarilyn Giordano, Coralie Henin, Julien Maurizio, et al.
Pageof 2